Medical Oncology Grand Rounds
Introduction
Medical Oncology Grand Rounds begin each year after completion of the Friday Introduction to Cancer Management lectures. Fellows and faculty members give 30- to 60-minute, case-based discussions and literature reviews on subjects of their choosing.
Schedule
Friday, Noon-1:00 PM
11th Floor Mid Campus Center, Main Conference Room (in person)
Zoom (virtual)
2022-2023 Academic Year
| Date | Speaker | Title | |
| Sep 16, 2022 | Andrew Chow | Mobilizing the Full Immunological Armamentarium in Lung Cancer | |
| Sep 23, 2022 | Jeffrey Aldrich | Highlights From Research in Supportive Care and Outcome Disparities in Breast Cancer | |
| Oct 14, 2022 EPNEC Seminar Room A |
Trever Bivona, MD, PhD University of California San Francisco |
Emerging Insights Into Oncogenic RTK-RAS Signaling | |
| Oct 28, 2022 | Stefan Tarnawsky | Update to the Prognostication and Classification of Myelodysplastic Syndromes | |
| Nov 4, 2022 | Mohammad Atiq, MD National Institutes of Health |
Exploring Immunocytokine Synergy With Chemotherapy in Metastatic Prostate Cancer | |
| Nov 11, 2022 | Katherine Weilbaecher | Breast Cancer Metastasis in Bone: Insights Into Old Therapies and New Approaches | |
| Dec 16, 2022 | Maria B. Magella Doyle, MD Department of Surgery |
Transplant Oncology - Making New Strides in Cancer Care | |
| Jan 6, 2023 | Brad Kahl | Mantle Cell Lymphoma - What Did We Learn in 2022? | |
| Jan 13, 2023 | Arvind Ravi, MD, PhD Dana-Farber Cancer Institute |
Integrative Approaches to Understanding Therapeutic Response and Resistance | |
| Jan 20, 2023 | Thomas Westbrook, MD University of Michigan |
Lineage Plasticity in Prostate Cancer: Mechanistic Insight and Therapeutic Implications | |
| Jan 27, 2023 | David Russler-Germain | Follicular Lymphoma: New Insights, Treatments, and Opportunities | |
| Feb 3, 2023 | Kelly Bolton | Germline Genetic Predisposition to Cancer: Paradigm Shifts and Practical Application in Oncology Care | |
| Feb 10, 2023 | Raya Saba | Management of Diffuse Large B-Cell Lymphoma in Older Patients | |
| Feb 17, 2023 | Ron Bose | Trastuzumab Deruxtecan in Breast, Lung, and Gastroesophageal Cancers | |
| Feb 24, 2023 | Fahrettin Covut | CAR T-Cell and Bispecific Therapies for Relapsed Refractory Multiple Myeloma | |
| Mar 3, 2023 | Kian-Huat Lim | Targeting Tumor Innate Inflammation in GI Cancers | |
| Mar 10, 2023 | Christopher Maher | Altered Noncoding Regulation Across Solid Tumors | |
| Mar 17, 2023 | Priyanka Verma | Targeting Base Damage Repair to Overcome Limitations of PARP Inhibitor Thaerapy in BRCA-Mutant Cancers | |
| Mar 24, 2023 Holden Auditorium |
Norman "Ned" Sharpless, MD University of North Carolina |
Ending Cancer as We Know It: Forecasting Future Cancer Progress | |
| Mar 31, 2023 | Akash Patnaik, MD, PhD, MMSc University of Chicago |
Activating Innate Immunity in Prostate Cancer: From Bedside to Bench and Back | |
| Apr 7, 2023 | Tanner Johanns | ||
| Apr 14, 2023 | Andrew Young | ||
| Apr 21, 2023 | Michael Iglesia | ||
| Apr 28, 2023 | Nathan Singh | ||
| May 5, 2023 | Nicole Foley | ||
| May 12, 2023 | Michael Kramer | ||
| May 19, 2023 | Matthew Christopher | ||
| May 26, 2023 | Jared Cohen | ||
| Jun 2, 2023 | Canceled - ASCO Meeting |
||
| Jun 9, 2023 | Andrea Hagemann, MD Department of Obstetrics & Gynecology |
||
| Jun 16, 2023 | Michael Slade | ||
| Jun 23, 2023 | Giordano Cittolin-Santos | ||
| Jun 30, 2023 | Jesse Zaretsky |
